Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
SPECIAL FEATURE - Bioavailability & Solubility: A Demand for Enhanced Technologies & Materials is Spurring Innovation March 3, 2015
Contributor Cindy H. Dubin spoke with several contract research/manufacturing organizations on how they are successfully overcoming solubility/bioavailability challenges, such as matching APIs to formulations and choosing the best excipients.
MARKET BRIEF - Miniaturizing Healthcare - From Microelectronics to Nanobiosensing March 3, 2015
Cecilia Van Cauwenberghe, MS, Technical Insights Senior Research Analyst, Frost & Sullivan, reports that the proliferation of lower cost microfluidics-based genomics tools offering improved capabilities and allowing more access to end-users is expected to drive this technology for pharmaceutical and biomedical research throughout the next 5 years.
XstalBio Issued US Patent for Stabilization of Therapeutic Proteins March 2, 2015
XstalBio Ltd a biologic formulation and drug delivery company recently announced the United States Patent and Trademark Office has issued...DYNAMIC LIGHT SCATTERING - Colloidal Gold: The Gold Standard for Drug Delivery? March 2, 2015
Stephen Ball explores the importance of particle size in biomedical nanotechnology. Experimental data are presented to illustrate how advanced DLS techniques deliver these measurements for colloidal gold in the nanosized and sub-nanosized ranges.
Strategic Science & Technologies Initiates Phase I Study to Evaluate Topical Sildenafil February 10, 2015
Strategic Science & Technologies recently announced the initiation of a Phase I trial of SST-6006, a first-in-class topical sildenafil product...ADVANCED DELIVERY DEVICES - Innovation Without Change: What is it & What Can it Mean for Pharmaceutical Manufacturers? January 7, 2015
John A. Merhige, MEM, and Dan Thayer believe a rigorous, risky development and regulatory process forces pharmaceutical manufacturers into a bad compromise between advances in delivery systems and the time, cost, and risk associated with those advances.
Insys Therapeutics Receives FDA Orphan Drug Designation December 16, 2014
Insys Therapeutics, Inc. recently announced that the US FDA has granted orphan drug designation (ODD) to its Liposome Entrapped Paclitaxel...GLOBAL DELIVERY MARKET - Advanced Drug Delivery Systems: mAb, RNAi, & Breaking the Blood-Brain Barrier November 19, 2014
Kevin James, Shalini Dewan, MS, Kim Lawson, and Usha Nagavarapu believe advances in understanding human biology and diseases are opening new and exciting possibilities in the biotechnology industry. R&D spending, along with increasing competition, patent expiries, and new and emerging technologies will continue to shape growth in this market for the foreseeable future.
ABUSE-DETERRENT MARKET - What’s in the Pipeline? Abuse-Deterrent Products November 18, 2014
Tugrul Kararli, PhD, MBA, Kurt Sedo, and Josef Bossart, PhD, decided it would be interesting to interrogate the PharmaCircle database and see what successes have been achieved with respect to abuse-deterrent formulations in terms of approved and pipeline products.
DNA VACCINES MARKET - DNA Vaccines: Strategic Markets & Emerging Technologies November 17, 2014
Kevin James, Shalini Dewan, MS, and Jon Evans, MBA, say the global market for DNA vaccines is estimated at $305.3 million for 2014 and is forecast to grow at a stellar 54.8% compound annual growth rate (CAGR) to reach $2.7 billion by 2019.
Acorda Therapeutics to Acquire Civitas Therapeutics September 30, 2014
Acorda Therapeutics, Inc. recently announced it entered into an agreement to acquire Civitas Therapeutics, a privately held biopharmaceutical company, for...Implementing Innovations in Injectable Drug Delivery With the User & Pharmaceutical Manufacturer in Mind September 23, 2014
By: John A. Merhige, Chief Commercial Officer, and Dan Thayer, Technology Director, Credence MedSystems, Inc. The Current Climate Change is...SPECIAL FEATURE - Injectable Drug Delivery: Safer, Simpler, Smarter Devices September 4, 2014
Contributor Cindy H. Dubin speaks with some of the leading companies operating in the injectables arena, and discovers this ever-evolving sector is witnessing some very specific and eye-opening trends that are affecting the market’s growth.
SPECIAL FEATURE - Patients & Physicians Desire Transdermal, Topical & Subcutaneous Delivery July 9, 2014
Contributor Cindy H. Dubin recently interviewed several topical, transdermal, and subcutaneous product manufacturers to find out how they are working with patients and physicians to develop delivery systems that meet their needs for comfort, compliance, and more effective delivery.
INJECTABLE MICROEMULSIONS - Prolonged-Release Injectable Microemulsions: Opportunities for Pain Treatment June 4, 2014
Rajesh Dubey, PhD, and Luigi G. Martini, FRPharmS, MBA, indicate available technologies do not support development of certain formulations to treat pain; however, microemulsions with their unique features, can provide a viable alternative to develop such formulations.
Capsugel & Bend Research Announce New Commercial-Scale Spray-Dried Dispersion Capacity June 3, 2014
Bend Research, a division of Capsugel Dosage Form Solutions (DFS), recently announced it has installed its first commercial-scale spray-dryer in...EXECUTIVE INTERVIEW - 4P Therapeutics: Developing New & Innovative Transdermal Products June 3, 2014
Drug Development Executive: Steven Damon, Founder of 4P Therapeutics, discusses his vision for the company and how 4P intends to create new and innovative transdermal products that meet the needs of patients, physicians, and payers.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing - Product Differentiation Is Critical May 8, 2014
Contributor Cindy H. Dubin speaks with several of these suppliers and manufacturers about the importance of customization and differentiation as the key to pharma companies staying competitive in the prefilled syringe space.
Prosonix & Mylan Enter Global Licensing Agreement April 22, 2014
Prosonix recently announced it has entered into a global licensing agreement with Mylan Inc. for its leading inhaled respiratory products,...Oval Medical Receives Funding to Progress Container for Autoinjector Techgnology April 22, 2014
Oval Medical Technologies Limited recently announced it has received a Smart funding award from the UK’s innovation agency, the Technology...Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...
